Connect with UMGCC
Email page
Print page
Email page
Print page
Loading
- Patient Care
- Being Admitted
- UMGCC Directory
- Schedule an Appointment
- Ask the Expert
- Patient Education
- Dictionary of Cancer Terms
- Parking, Lodging and Restaurants
- Podcasts
- Audio/Video Library
Related Resources- Center for Image Renewal
- Clinical Trials
- Contact Us
- Patient Web Pages
Home >Information for Patients > Dictionary Index
Dictionary of Cancer Terms
View in Spanish: Nimotuzumab
Nimotuzumab (ny-moh-TOO-zoo-mab)
A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Nimotuzumab binds the epidermal growth factor receptor (EGFR) and blocks cancer cells that depend on epidermal growth factor for growth. Also called Theraloc.
Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.
Email this Page
Print this Page
If you would like to make an appointment or talk to someone about our services, please call 1-800-888-8823.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
© 2011 University of Maryland Greenebaum Cancer Center. All rights reserved.
22 S. Greene Street, Baltimore, MD 21201
22 S. Greene Street, Baltimore, MD 21201
